The quality of drug studies published in symposium proceedings

Annals of Internal Medicine

Volumn 124, Issue 5, 1996, Pages 485-489

  Cho, Mildred K ^a   Bero, Lisa A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DATA ANALYSIS; DRUG INDUSTRY; DRUG RESEARCH; FINANCE; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0030068045     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-5-199603010-00004     Document Type: Article

References (25)

1. Manning PR, Denson TA. How internists learned about cimetidine. Ann Intern Med. 1980;92 690-2.
2. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4-8
3. Rennie D, Bero LA. Throw it away, Sam the controlled circulation journals. AJR Am J Roentgenol. 1990;155:889-92
4. Bero LA, Galbraith A, Rennie D. The publication of sponsored symposiums in medical journals. N Engl J Med. 1992;327:1135-40.
5. Davidson RA. Source of funding and outcome of clinical trials J Gen Intern Med. 1986;1 155-8.
6. Rochon PA, Gurwitz, JH, Simms RW, Fortin PR, Felson DT, Minaker KL, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis Arch Intern Med 1994;154:157-163
7. Cho MK, Bero LA. Instruments for assessing the quality of drug studies published in the medical literature. JAMA 1994;272:101-4.
8. Hemminki E. Quality of clinical trials - a concern of three decades. Methods Inf Med 1982;21 81-5.
9. DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials N Engl J Med 1982;306 1332-7
10. Andrew E. Eide H, Fuglerud P, Hagen EK, Kristoffersen DT, Lambrechts M, et al. Publications on clinical trials with X-ray contrast media: differences in quality between journals and decades Eur J Radiol 1990;10:92-6
11. Siegel S, Castellan NJ Jr. Nonparametric Statistics for the Behavioral Sciences New York McGraw-Hill, 1988.
12. Haggard EA. Intraclass Correlation and the Analysis of Variance. New York Dryden Pr; 1958
13. Gotzsche PC. Reference bias in reports of drug trials. Br Med J (Clin Res Ed) 1987;295 654-6.
14. Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal JAMA 1994;272:108-13
15. Food and Drug Administration. Offices of Drug Evaluation Statistical Report Washington, DC. Center for Drug Evaluation and Research; 1990
16. Simes RJ. Publication bias: the case for an international registry of clinical trials J Clin Oncol. 1986;4 1529-41.
17. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-72
18. Dickersin K, Chan S. Chalmers TC, Sacks HS, Smith H Jr. Publication bias and clinical trials. Controlled Clin Trials. 1987;8 343-53.
19. Rosenthal R. Summarizing significance levels New Directions for Methodology of Social and Behavioral Science 1980;5:33-46.
20. Hemminki E. Study of information submitted by drug companies to licensing authorities. BMJ. 1980;280 833-6
21. Colditz G, Miller J, Mosteller F. How study design affects outcomes in comparisons of therapy I medical. Stat Med. 1989;441-54
22. Dieppe P, Frankel S, Toth B. Is research into the treatment of osteoarthritis with nonsteroidal anti-inflammatory drugs misdirected? Lancet 1993;341 353-4
23. Gotzsche P. Meta-analysis of NSAIDS contribution of drugs, doses, trial designs, and meta-analytic techniques. Scand J Rheumatol. 1993;22 255-60.
24. Dickersin K, Min YI, Meinert CL Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards JAMA 1992;267 374-8
25. A proposal for structured reporting of randomized controlled trials The Standards of Reporting Trials Group JAMA 1994;272:1926-31